Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1997 Feb;43:259–265.

Medical management of intestinal obstruction in terminal care.

C Frank 1
PMCID: PMC2255220  PMID: 9040913

Abstract

OBJECTIVE: To review the evidence on the effectiveness of medical management of bowel obstruction for patients with advanced cancer and to summarize treatment options for home and hospital care. DATA SOURCES: Articles were identified by searching MEDLINE. STUDY SELECTION: Research articles published between 1973 and 1995 on the surgical and medical management of bowel obstruction in patients with advanced cancer were identified. Seven original research articles on medical management were identified and all were reviewed and critically appraised. Given the small number of original papers in this field, studies using prospective and retrospective methodology were included. Articles looking only at the use of percutaneous gastrostomy tubes and subcutaneous hydration were used in the formulation of treatment recommendations but were not critically reviewed. A critical appraisal of the surgical literature was not undertaken. SYNTHESIS: Recommendations regarding medical management of bowel obstruction were based on strength of evidence for improving symptoms with pharmacologic treatment. The few clinical trials were uncontrolled trials with small samples. The trials show improvement of symptom control with pharmacologic management using morphine, anticholinergics, major tranquilizers, corticosteroids, and somatostatin analogues. Intravenous hydration was unnecessary for most patients. Percutaneous gastrostomy tubes are effective for patients with proximal intestinal obstruction and intractable vomiting. CONCLUSIONS: Pharmacologic management and percutaneous gastrostomy for intractable vomiting and hypodermoclysis or oral fluids for hydration can control symptoms without surgery or nasogastric tubes.

Full text

PDF
259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aabo K., Pedersen H., Bach F., Knudsen J. Surgical management of intestinal obstruction in the late course of malignant disease. Acta Chir Scand. 1984;150(2):173–176. [PubMed] [Google Scholar]
  2. Aranha G. V., Folk F. A., Greenlee H. B. Surgical palliation of small bowel obstruction due to metastatic carcinoma. Am Surg. 1981 Mar;47(3):99–102. [PubMed] [Google Scholar]
  3. Arnold R., Lankisch P. G. Somatostatin and the gastrointestinal tract. Clin Gastroenterol. 1980 Sep;9(3):733–753. [PubMed] [Google Scholar]
  4. Baines M., Oliver D. J., Carter R. L. Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study. Lancet. 1985 Nov 2;2(8462):990–993. doi: 10.1016/s0140-6736(85)90534-3. [DOI] [PubMed] [Google Scholar]
  5. Chan A., Woodruff R. K. Intestinal obstruction in patients with widespread intraabdominal malignancy. J Pain Symptom Manage. 1992 Aug;7(6):339–342. doi: 10.1016/0885-3924(92)90086-w. [DOI] [PubMed] [Google Scholar]
  6. Dharmsathaphorn K., Gorelick F. S., Sherwin R. S., Cataland S., Dobbins J. W. Somatostatin decreases diarrhea in patients with the short-bowel syndrome. J Clin Gastroenterol. 1982 Dec;4(6):521–524. doi: 10.1097/00004836-198212000-00008. [DOI] [PubMed] [Google Scholar]
  7. Fainsinger R. L., Spachynski K., Hanson J., Bruera E. Symptom control in terminally ill patients with malignant bowel obstruction (MBO). J Pain Symptom Manage. 1994 Jan;9(1):12–18. doi: 10.1016/0885-3924(94)90141-4. [DOI] [PubMed] [Google Scholar]
  8. Farr W. C. The use of corticosteroids for symptom management in terminally ill patients. Am J Hosp Care. 1990 Jan-Feb;7(1):41–46. doi: 10.1177/104990919000700107. [DOI] [PubMed] [Google Scholar]
  9. Fernandes J. R., Seymour R. J., Suissa S. Bowel obstruction in patients with ovarian cancer: a search for prognostic factors. Am J Obstet Gynecol. 1988 Feb;158(2):244–249. doi: 10.1016/0002-9378(88)90131-7. [DOI] [PubMed] [Google Scholar]
  10. Gallick H. L., Weaver D. W., Sachs R. J., Bouwman D. L. Intestinal obstruction in cancer patients. An assessment of risk factors and outcome. Am Surg. 1986 Aug;52(8):434–437. [PubMed] [Google Scholar]
  11. Gemlo B., Rayner A. A., Lewis B., Wong A., Viele C. S., Ungaretti J. R., DeLorimier A. A., Hohn D. C. Home support of patients with end-stage malignant bowel obstruction using hydration and venting gastrostomy. Am J Surg. 1986 Jul;152(1):100–104. doi: 10.1016/0002-9610(86)90155-8. [DOI] [PubMed] [Google Scholar]
  12. Khoo D., Hall E., Motson R., Riley J., Denman K., Waxman J. Palliation of malignant intestinal obstruction using octreotide. Eur J Cancer. 1994;30A(1):28–30. doi: 10.1016/s0959-8049(05)80012-7. [DOI] [PubMed] [Google Scholar]
  13. Kyllönen L. E. Obstruction and perforation complicating colorectal carcinoma. An epidemiologic and clinical study with special reference to incidence and survival. Acta Chir Scand. 1987 Oct;153(10):607–614. [PubMed] [Google Scholar]
  14. Larson J. E., Podczaski E. S., Manetta A., Whitney C. W., Mortel R. Bowel obstruction in patients with ovarian carcinoma: analysis of prognostic factors. Gynecol Oncol. 1989 Oct;35(1):61–65. doi: 10.1016/0090-8258(89)90012-7. [DOI] [PubMed] [Google Scholar]
  15. Lund B., Hansen M., Lundvall F., Nielsen N. C., Sørensen B. L., Hansen H. H. Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy. Surg Gynecol Obstet. 1989 Sep;169(3):213–218. [PubMed] [Google Scholar]
  16. Mercadante S. The role of octreotide in palliative care. J Pain Symptom Manage. 1994 Aug;9(6):406–411. doi: 10.1016/0885-3924(94)90178-3. [DOI] [PubMed] [Google Scholar]
  17. Picus D., Marx M. V., Weyman P. J. Chronic intestinal obstruction: value of percutaneous gastrostomy tube placement. AJR Am J Roentgenol. 1988 Feb;150(2):295–297. doi: 10.2214/ajr.150.2.295. [DOI] [PubMed] [Google Scholar]
  18. Reid D. B. Palliative management of bowel obstruction. Med J Aust. 1988 Jan 4;148(1):54–54. doi: 10.5694/j.1326-5377.1988.tb104494.x. [DOI] [PubMed] [Google Scholar]
  19. Ripamonti C. Management of bowel obstruction in advanced cancer patients. J Pain Symptom Manage. 1994 Apr;9(3):193–200. doi: 10.1016/0885-3924(94)90130-9. [DOI] [PubMed] [Google Scholar]
  20. Rousseau P. Antiemetic therapy in adults with terminal disease: a brief review. Am J Hosp Palliat Care. 1995 Jan-Feb;12(1):13–18. doi: 10.1177/104990919501200108. [DOI] [PubMed] [Google Scholar]
  21. Soo K. C., Davidson T., Parker M., Paterson I., Paterson A. Intestinal obstruction in patients with gynaecological malignancies. Ann Acad Med Singapore. 1988 Jan;17(1):72–75. [PubMed] [Google Scholar]
  22. Turnbull A. D., Guerra J., Starnes H. F. Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin. J Clin Oncol. 1989 Mar;7(3):381–386. doi: 10.1200/JCO.1989.7.3.381. [DOI] [PubMed] [Google Scholar]
  23. Ventafridda V., Ripamonti C., Caraceni A., Spoldi E., Messina L., De Conno F. The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori. 1990 Aug 31;76(4):389–393. doi: 10.1177/030089169007600417. [DOI] [PubMed] [Google Scholar]
  24. Walsh H. P., Schofield P. F. Is laparotomy for small bowel obstruction justified in patients with previously treated malignancy? Br J Surg. 1984 Dec;71(12):933–935. doi: 10.1002/bjs.1800711206. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES